Michael A. Kalata, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 29100 Gateway Blvd, Suite 300, Flat Rock, MI 48134 Phone: 734-379-0781 |
News Archive
The epidemic is proving a devastating obstacle to development, while taking an increasing and terrifying toll on Africa's women. But women also have an indispensable part to play in all aspects of the struggle against it.
Still feeling the residual effects of springing ahead for daylight saving time? The hour of sleep lost - or gained - may play a bigger, perhaps more dangerous role in our body's natural rhythm than we think. It seems moving the clock forward or backward may alter the timing of when heart attacks occur in the week following these time changes, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.
Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the U.S. National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany. The award of funds will help support the conduct of a Phase 2A clinical trial in patients with progressive forms of MS using MIS416, a naturally occurring agent derived from bacteria.
A CHEO-led multi-site North American study, headed by Dr. Robert Klaassen, lead investigator at CHEO and associate professor in the University of Ottawa's Department of Pediatrics, has confirmed the validity and reliability of a quality of life measurement tool for children and adults with thalassemia major.
SAS, the leader in business analytics software and services, and GE Healthcare have entered into a joint development and marketing agreement by which GE Healthcare will leverage SAS technology to analyze and deliver relevant, detailed patient safety information to help hospitals address preventable adverse medical events.
› Verified 2 days ago